tomentosin has been researched along with fluconazole in 1 studies
| Studies (tomentosin) | Trials (tomentosin) | Recent Studies (post-2010) (tomentosin) | Studies (fluconazole) | Trials (fluconazole) | Recent Studies (post-2010) (fluconazole) |
|---|---|---|---|---|---|
| 23 | 0 | 20 | 9,343 | 721 | 3,664 |
| Protein | Taxonomy | tomentosin (IC50) | fluconazole (IC50) |
|---|---|---|---|
| Lanosterol 14-alpha demethylase | Candida albicans SC5314 | 0.1296 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 9.21 | |
| Sterol 14-alpha demethylase | Trypanosoma cruzi strain CL Brener | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartlam, M; Guo, Y; Meng, L; Sun, L; Wang, M; Xie, C; Xu, J | 1 |
1 other study(ies) available for tomentosin and fluconazole
| Article | Year |
|---|---|
Sesquiterpenes from Carpesium macrocephalum inhibit Candida albicans biofilm formation and dimorphism.
Topics: Antifungal Agents; Asteraceae; Biofilms; Candida albicans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Molecular Structure; Sesquiterpenes | 2015 |